Nifty Pharma continues its fall. What should investors do with Dr Reddy’s and Alembic Pharma?

The NSE’s index of pharma stocks tanked more than 4% on Tuesday and is among the top underperformers. Investors booked profits in pharma stocks after their rally over the past year and a dip in daily COVID-19 infections.

from Moneycontrol Market Outlook https://www.moneycontrol.com/news/market-outlook/nifty-pharma-continues-its-fall-what-should-investors-dodr-reddy’salembic-pharma_15343681.html